Published in Schizophr Bull on January 26, 2012
Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 1.57
A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychol Med (2014) 1.47
Auditory verbal hallucinations in persons with and without a need for care. Schizophr Bull (2014) 1.32
Studying hallucinations within the NIMH RDoC framework. Schizophr Bull (2014) 1.24
Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr Bull (2012) 1.19
The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations. Mol Psychiatry (2013) 1.17
Better than mermaids and stray dogs? Subtyping auditory verbal hallucinations and its implications for research and practice. Schizophr Bull (2014) 1.16
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
Childhood adversities and psychosis: evidence, challenges, implications. World Psychiatry (2016) 1.01
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain (2013) 1.00
Impaired effort allocation in patients with schizophrenia. Schizophr Res (2014) 0.99
What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences? Schizophr Bull (2016) 0.91
A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophr Res (2013) 0.89
A synthesis of evidence on inhibitory control and auditory hallucinations based on the Research Domain Criteria (RDoC) framework. Front Hum Neurosci (2014) 0.88
Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study. Schizophr Res (2014) 0.87
Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation. Schizophr Bull (2014) 0.85
An Overview of the Association between Schizotypy and Dopamine. Front Psychiatry (2014) 0.84
Neuroimaging of voice hearing in non-psychotic individuals: a mini review. Front Hum Neurosci (2012) 0.84
Examining the Psychosis Continuum. Curr Behav Neurosci Rep (2015) 0.80
Molecular imaging as a guide for the treatment of central nervous system disorders. Dialogues Clin Neurosci (2013) 0.79
Schizotypal personality disorder: a current review. Curr Psychiatry Rep (2014) 0.79
Appraisals of psychotic experiences: an experimental investigation of symptomatic, remitted and non-need-for-care individuals. Psychol Med (2016) 0.77
Auditory verbal hallucinations in first-episode psychosis: a phenomenological investigation. BJPsych Open (2016) 0.77
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
Auditory verbal hallucinations and continuum models of psychosis: A systematic review of the healthy voice-hearer literature. Clin Psychol Rev (2016) 0.75
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? NPJ Parkinsons Dis (2017) 0.75
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab (1983) 9.59
Schizophrenia. Lancet (2009) 8.14
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2008) 5.61
The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat (2003) 5.16
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry (1992) 4.54
The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull (1991) 4.52
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry (2000) 4.35
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp (2003) 4.34
Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med (1999) 4.18
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys (1997) 3.14
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol (1999) 2.09
From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. Schizophr Res (2005) 2.00
Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol (1991) 1.80
Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol (2004) 1.75
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI). Schizophr Bull (2004) 1.69
Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects. Schizophr Bull (2008) 1.53
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des (2009) 1.51
The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry (2011) 1.49
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry (2011) 1.44
Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull (2011) 1.39
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet (1995) 1.37
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A (1994) 1.30
Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Arch Gen Psychiatry (2004) 1.26
The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry (2007) 1.18
PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist (2009) 1.16
Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa. Int J Rad Appl Instrum A (1992) 1.15
Multiresolution analysis of emission tomography images in the wavelet domain. J Cereb Blood Flow Metab (1999) 1.12
Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry (2007) 1.08
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuroimage (2009) 1.06
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging. Schizophr Res (2008) 0.98
Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med (2011) 0.88
Multi-resolution Bayesian regression in PET dynamic studies using wavelets. Neuroimage (2006) 0.87
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry (2012) 5.45
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry (2012) 4.54
Efficiency of functional brain networks and intellectual performance. J Neurosci (2009) 4.25
Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp (2009) 4.22
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry (2006) 3.86
Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci (2010) 3.80
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One (2009) 3.41
Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp (2007) 3.15
Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol (2012) 3.05
Affective state and decision-making in the Ultimatum Game. Exp Brain Res (2006) 2.91
Do women really have more bilateral language representation than men? A meta-analysis of functional imaging studies. Brain (2004) 2.86
Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry (2007) 2.70
Effect of early intervention on 5-year outcome in non-affective psychosis. Br J Psychiatry (2010) 2.68
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res (2004) 2.61
Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp (2009) 2.55
Cannabis use and age at onset of schizophrenia. Am J Psychiatry (2004) 2.49
Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry (2013) 2.47
High-cost, high-capacity backbone for global brain communication. Proc Natl Acad Sci U S A (2012) 2.42
Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry (2003) 2.41
Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry (2012) 2.39
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain (2008) 2.35
The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry (2012) 2.34
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry (2008) 2.28
The association between brain volume and intelligence is of genetic origin. Nat Neurosci (2002) 2.21
Dysconnectivity in schizophrenia: where are we now? Neurosci Biobehav Rev (2010) 2.16
Lateralization of amygdala activation: a systematic review of functional neuroimaging studies. Brain Res Brain Res Rev (2004) 2.05
Use of human spironolactone in dogs with heart failure. Vet Rec (2008) 2.04
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study. Am J Psychiatry (2015) 2.02
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98
Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull (2012) 1.97
Genetic contributions to human brain morphology and intelligence. J Neurosci (2006) 1.97
Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry (2007) 1.95
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.90
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology (2008) 1.88
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry (2011) 1.83
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull (2008) 1.80
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry (2010) 1.76
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull (2011) 1.72
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry (2007) 1.71
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics (2012) 1.70
Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biol Psychiatry (2011) 1.70
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry (2010) 1.69
Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol (2005) 1.69
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev (2007) 1.67
Diagnostic stability in a Dutch psychosis incidence cohort. Br J Psychiatry (2004) 1.67
White matter microstructure in schizophrenia: effects of disorder, duration and medication. Br J Psychiatry (2009) 1.66
Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci Biobehav Rev (2012) 1.62
Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophr Res (2007) 1.60
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. Am J Psychiatry (2010) 1.55
Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects. Schizophr Bull (2008) 1.53
Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex affects strategic decision-making. Neuroreport (2005) 1.52
Function of striatum beyond inhibition and execution of motor responses. Hum Brain Mapp (2005) 1.51
Effects of δ9-tetrahydrocannabinol on human working memory function. Biol Psychiatry (2012) 1.51
Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology (2008) 1.50
Cognitive relevance of the community structure of the human brain functional coactivation network. Proc Natl Acad Sci U S A (2013) 1.49
The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry (2011) 1.49
Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum Brain Mapp (2011) 1.48
A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One (2012) 1.45
Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Hum Brain Mapp (2009) 1.43
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry (2009) 1.40
Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol (2009) 1.40
Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J Autism Dev Disord (2008) 1.39
Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull (2011) 1.39
Pathological crying after subthalamic nucleus stimulation. Mov Disord (2013) 1.37
Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biol Psychiatry (2010) 1.34
The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull (2012) 1.34
Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res (2003) 1.31
Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp (2004) 1.31
Cardiorespiratory effects on default-mode network activity as measured with fMRI. Hum Brain Mapp (2009) 1.30
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry (2011) 1.30
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain (2009) 1.29
Expectations and violations: delineating the neural network of proactive inhibitory control. Hum Brain Mapp (2012) 1.28
Increased gray-matter volume in medication-naive high-functioning children with autism spectrum disorder. Psychol Med (2005) 1.27
Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry (2002) 1.27
Prognostic prediction of therapeutic response in depression using high-field MR imaging. Neuroimage (2010) 1.26
Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS One (2008) 1.26
Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry (2008) 1.25
Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol (2010) 1.24